JP2024532768A5 - - Google Patents

Info

Publication number
JP2024532768A5
JP2024532768A5 JP2024508407A JP2024508407A JP2024532768A5 JP 2024532768 A5 JP2024532768 A5 JP 2024532768A5 JP 2024508407 A JP2024508407 A JP 2024508407A JP 2024508407 A JP2024508407 A JP 2024508407A JP 2024532768 A5 JP2024532768 A5 JP 2024532768A5
Authority
JP
Japan
Prior art keywords
group
pharmaceutically acceptable
stereoisomer
acceptable salt
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532768A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/113499 external-priority patent/WO2023020605A1/zh
Publication of JP2024532768A publication Critical patent/JP2024532768A/ja
Publication of JP2024532768A5 publication Critical patent/JP2024532768A5/ja
Pending legal-status Critical Current

Links

JP2024508407A 2021-08-19 2022-08-19 カンプトテシン誘導体、その薬物組成物およびその応用 Pending JP2024532768A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN202110955364 2021-08-19
CN202110955364.5 2021-08-19
CN202111515247.3 2021-12-13
CN202111515247 2021-12-13
CN202210515797 2022-05-12
CN202210515797.3 2022-05-12
PCT/CN2022/113499 WO2023020605A1 (zh) 2021-08-19 2022-08-19 喜树碱衍生物、其药物组合物及其应用

Publications (2)

Publication Number Publication Date
JP2024532768A JP2024532768A (ja) 2024-09-10
JP2024532768A5 true JP2024532768A5 (cg-RX-API-DMAC7.html) 2025-08-27

Family

ID=85239565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508407A Pending JP2024532768A (ja) 2021-08-19 2022-08-19 カンプトテシン誘導体、その薬物組成物およびその応用

Country Status (8)

Country Link
US (1) US20250270227A1 (cg-RX-API-DMAC7.html)
EP (1) EP4389752A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024532768A (cg-RX-API-DMAC7.html)
KR (1) KR20240049583A (cg-RX-API-DMAC7.html)
CN (1) CN117769555A (cg-RX-API-DMAC7.html)
AU (1) AU2022330892A1 (cg-RX-API-DMAC7.html)
CA (1) CA3228345A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023020605A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024510435A (ja) 2021-03-18 2024-03-07 シージェン インコーポレイテッド 生体活性化合物の内部移行複合体からの選択的薬物放出
KR20250004952A (ko) * 2022-03-17 2025-01-08 씨젠 인크. 캄프토테신 접합체
JP2025515988A (ja) * 2022-05-13 2025-05-23 シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド カンプトテシン化合物、その調製方法及びその使用
IL322897A (en) * 2023-02-23 2025-10-01 Phrontline Biopharma Hangzhou Co Ltd Camptothecin derivatives and conjugates, methods for their preparation and medical uses
WO2024210687A1 (ko) * 2023-04-06 2024-10-10 주식회사 피노바이오 항암 내성 극복을 위한 신규 캄토테신 유도체 및 이를 포함하는 항체-약물 접합체
CN120858098A (zh) * 2023-05-04 2025-10-28 四川科伦博泰生物医药股份有限公司 稠环化合物及其制备方法和应用
CN120826405A (zh) * 2023-05-04 2025-10-21 四川科伦博泰生物医药股份有限公司 具有靶向作用的偶联物及其制备方法和用途
WO2025153001A1 (zh) * 2024-01-17 2025-07-24 北京泰德制药股份有限公司 含有噻唑[5,4-b]吡啶结构的抗体偶联药物及其用途
WO2026130566A1 (zh) * 2024-12-20 2026-06-25 上海复宏汉霖生物技术股份有限公司 一种配体-药物偶联物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0540099T3 (da) * 1991-10-29 1996-06-17 Glaxo Wellcome Inc Vandopløselige camptothecinderivater
CN1036197C (zh) * 1992-01-28 1997-10-22 格拉克索有限公司 水溶性喜树碱衍生物
JPH1171280A (ja) * 1997-06-26 1999-03-16 Tanabe Seiyaku Co Ltd 医薬組成物
CN111936169A (zh) * 2018-04-06 2020-11-13 西雅图遗传学公司 喜树碱肽缀合物
TWI920652B (zh) * 2018-06-07 2026-04-01 美商思進公司 喜樹鹼結合物
RS64961B1 (sr) 2019-04-26 2024-01-31 Immunogen Inc Derivati kamptotecina
AU2022216696A1 (en) * 2021-02-05 2023-08-17 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Camptothecin compound, preparation method therefor, and application thereof
CN120093941A (zh) * 2021-02-09 2025-06-06 苏州宜联生物医药有限公司 生物活性物偶联物及其制备方法和用途
KR20240031235A (ko) * 2021-05-27 2024-03-07 자임워크스 비씨 인코포레이티드 캄프토테신 유사체, 접합체 및 사용 방법
CN117940432B (zh) * 2021-09-01 2025-12-23 上海弼领生物技术有限公司 一种喜树碱类化合物、其制备方法和用途
KR20250004952A (ko) * 2022-03-17 2025-01-08 씨젠 인크. 캄프토테신 접합체
WO2023217227A1 (zh) * 2022-05-12 2023-11-16 先声再明医药有限公司 喜树碱类衍生物及配体-药物偶联物
JP2025515988A (ja) * 2022-05-13 2025-05-23 シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド カンプトテシン化合物、その調製方法及びその使用

Similar Documents

Publication Publication Date Title
JP2015504081A5 (cg-RX-API-DMAC7.html)
JP2014504622A5 (cg-RX-API-DMAC7.html)
JP2017524025A5 (cg-RX-API-DMAC7.html)
JP2010524932A5 (cg-RX-API-DMAC7.html)
JP2017523169A5 (cg-RX-API-DMAC7.html)
JP2014503574A5 (cg-RX-API-DMAC7.html)
JP2018531941A5 (cg-RX-API-DMAC7.html)
JP2014506907A5 (cg-RX-API-DMAC7.html)
JP2013523614A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
JP2013510120A5 (cg-RX-API-DMAC7.html)
JP2018529690A5 (cg-RX-API-DMAC7.html)
JP2014510774A5 (cg-RX-API-DMAC7.html)
JP2010530372A5 (cg-RX-API-DMAC7.html)
JP2015522650A5 (cg-RX-API-DMAC7.html)
JP2013056919A5 (cg-RX-API-DMAC7.html)
JP2014500861A5 (cg-RX-API-DMAC7.html)
JP2015535847A5 (cg-RX-API-DMAC7.html)
JP2011528658A5 (cg-RX-API-DMAC7.html)
JP2015516427A5 (cg-RX-API-DMAC7.html)
JP2010504343A5 (cg-RX-API-DMAC7.html)
JP2014500296A5 (cg-RX-API-DMAC7.html)
JP2012512863A5 (cg-RX-API-DMAC7.html)
RU2011153934A (ru) Соли бициклозамещенных производных азопиразолона, способ их получения и применение
JP2017538767A5 (cg-RX-API-DMAC7.html)